Deva Holding A.Ş.

Overview

Deva Holding A.Ş. is a leading pharmaceutical company in Turkey specializing in the development, production, and marketing of human pharmaceutical products. The company focuses on generic drug production and has a reputation for high quality and reliable therapies.

Therapeutic areas

API / Drug Master Files

Deva Holding A.Ş. holds 6 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ELTROMBOPAG OLAMINEActive2026-02-26
• OLAPARIBActive2026-02-26
• DASATINIBActive2024-08-27
• POMALIDOMIDEActive2024-03-05
• ISOPROTERENOL HYDROCHLORIDE USPActive2022-05-12
• LENALIDOMIDEActive2021-12-09

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Deva Holding A.Ş. in our records. PharmaTek screens the full directory against live FDA enforcement data.